Cardiovascular disease is the leading cause of death for both men and women worldwide. Treatment of high cholesterol and blood pressure has been shown to reduce risks but often requires daily administration of multiple drugs resulting in patient compliance issues. Lack of patient adherence to a prescribed regimen compromises patient safety, and escalates costs to patients and healthcare systems.
Matrx’s proprietary polymeric drug delivery platforms provide a safe and convenient approach to the delivery of cardiovascular medicines over extended periods. Furthermore, the capability of Martx’s platforms to deliver multiple compounds simultaneously, improves patient compliance by reducing the frequency and number of required doses, while also providing efficient, lower cost treatment options.